Sareum welcomes more patent protection for anti-cancer candidate
Tim Mitchell, Sareum’s chief executive, said: "SRA737 is a valuable asset to Sareum through its licence to Sierra Oncology. "
Company
Sareum Holdings PLC
LON:SAR
Sareum Holdings (AIM:SAR) is a clinical-stage biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer. The Company is focused on developing next generation small molecules which modify the activity of the JAK kinase family and have best-in-class potential. Its lead candidate, SDC-1801, simultaneously inhibits TYK2 and JAK1. SDC-1801 is a potential treatment for a range of autoimmune diseases, including psoriasis, and has completed Phase 1 clinical development.
239 stories · page 10 of 12
FTSE 100 closes lower as election worries dent sentiment
The FTSE 100 closed down 6.56, or 0.09% to 7,519...
Archive
Sierra Oncology to present data on trials using Sareum's Chk1 inhibitor
Sierra holds exclusive rights to SRA737, having licensed the programme from Sareum's co-investment partner, the CRT Pioneer Fund
Sareum to present at leading European biopharma conference this week
Chief executive Tim Mitchell will be giving two presentations today and tomorrow at BioTrinity in Hammersmith, London
EQTEC steps on gas as parent converts loan
Some of the largest rises and falls in London at 3.15pm: EQTEC, Goldplat, Feedback
Sareum posts maiden profit after cancer drug payment
The Sierra licence triggered an upfront payment to Sareum
Investments and investor services
FTSE closes flat as Unilever holds market back
The FTSE 100 ended flat on Monday as Unilever shares sank in the wake of Kraft Heinz saying it had abandoned its proposed merger which would have been one of the biggest in corporate history
Archive
Proactive news round-up: Orogen Gold, Braveheart Investment, Concepta ...
A glance at some of the stories on the Proactive newswire today
Sareum boosted by second cancer milestone payment
Sareum is entitled to 27.5% of all payments arising from the Chk1 licence agreement
Risers and fallers: Next, Sirius Minerals, Victoria Oil & Gas
Shares in Victoria Oil & Gas were up after it spudded two development wells at its Logbaba gas field in Cameroon
“Strong” 2016 leaves Sareum in good shape for growth
The past year has seen the company go from strength to strength, culminating in the licensing of its most advanced programme
Small Cap highlights: Sareum leads Monday’s stand-out small cap biotech stocks
Sareum, Faron, WideCells, Abzena and Ergomed were among Monday's small cap highlights